0001213900-24-014906.txt : 20240216 0001213900-24-014906.hdr.sgml : 20240216 20240216161516 ACCESSION NUMBER: 0001213900-24-014906 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240101 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSPIRE VETERINARY PARTNERS, INC. CENTRAL INDEX KEY: 0001939365 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 854359258 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41792 FILM NUMBER: 24648512 BUSINESS ADDRESS: STREET 1: 780 LYNNHAVEN PKWY #400 CITY: VIRGINIA BEACH STATE: VA ZIP: 23452 BUSINESS PHONE: (757) 288-3088 MAIL ADDRESS: STREET 1: 780 LYNNHAVEN PKWY #400 CITY: VIRGINIA BEACH STATE: VA ZIP: 23452 8-K 1 ea193965-8k_inspire.htm CURRENT REPORT
false 0001939365 0001939365 2024-01-01 2024-01-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 16, 2024 (January 1, 2024)

 

INSPIRE VETERINARY PARTNERS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-41792   85-4359258
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)

 

780 Lynnhaven Parkway, Suite 400

Virginia Beach, VA

   23452
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (757) 734-5464

 

N/A

(Former name or former address, if changed since last report)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, par value $0.0001   IVP   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Inspire Veterinary Partners, Inc. (“Inspire” or the “Company”) has entered into an employment agreement (the “Employment Agreement”) with Richard Frank, the Company’s current Chief Financial Officer. Mr. Frank’s appointment as Chief Financial Officer had previously become effective upon consummation of Inspire’s initial public offering on August 31, 2023 and his Employment Agreement is effective as of January 1, 2024. The Employment Agreement provides for an initial one-year term with the ability to renew, upon the affirmative vote of the board of directors of the Company, for successive one-year terms.

 

Pursuant to the Employment Agreement, Mr. Frank’s duties consist of devoting as much time as is necessary to perform the duties and services required under the Employment Agreement and as may be designated by the Chief Executive Officer, and devoting his best efforts to the business and affairs of Inspire and promoting the interests of Inspire. Mr. Frank is barred from directly or indirectly engaging in any other business that could reasonably be expected to detract from his ability to apply his best efforts in the performance of his duties to Inspire.

 

The Employment Agreement provides that Mr. Frank will receive a base salary of $210,000 per annum. The base salary will be reviewed at the end of each fiscal year and any recommended changes will be subject to approval of the board of directors of the Company. Mr. Frank is eligible for annual bonuses subject to satisfaction of both a “Revenue Target” and a “Profit Target”, as follows:

 

Revenue Bonus: The “Revenue Target” is 100% of budgeted revenue of Inspire for the calendar year, and the “Revenue Bonus Target” is 15% of Mr. Frank’s annual base salary.

 

Annual Revenue Compared to Revenue Target   Revenue Bonus
110% or greater   125% of Revenue Bonus Target
100 – 109%   100% of Revenue Bonus Target
95 – 99%   95% of Revenue Bonus Target
90 – 94%   90% of Revenue Bonus Target
Below 90%   No Revenue Bonus

 

Profit Bonus: The “Profit Target” is 100% of budgeted profit of Inspire for the calendar year, and the “Profit Bonus Target” is 15% of Mr. Frank’s annual base salary.

 

Actual Profit Compared to Profit Target   Profit Bonus
110% or greater   125% of Profit Bonus Target
100-109%   100% of Profit Bonus Target
95-99%   95% of Profit Bonus Target
90-94%   90% of Profit Bonus Target
Below 90%   No Profit Bonus

 

In addition, the Employment Agreement provides that Mr. Frank is eligible to be awarded, in the board of directors’s sole discretion, shares of Class A common stock based on the Company’s performance for each calendar year based on the applicable Revenue Target and Profit Target for such calendar year. Any such stock award will be equal to 10% and 14% of Mr. Frank’s base salary and will be fully vested upon issuance.

 

Mr. Frank is entitled to participate in any employee benefit plans offered to the Company’s employees on the same terms and conditions as other employees.

 

The Employment Agreement contains certain non-disclosure and confidentiality provisions applicable to Mr. Frank for the benefit of the Company. Mr. Frank has also agreed, during the term of his employment and for a two-year period following the termination of his employment not to solicit for employment any employee or any person who was employed by the Company within the prior six months. Mr. Frank is also barred from soliciting any clients or certain former clients of the Company for a period of two years following the termination of his employment with the Company.

 

1

 

 

Inspire may terminate Mr. Frank’s employment immediately for cause upon:

 

●his death;

 

●his mental or physical incapacity that prevents him, with or without reasonable accommodation, from performing his essential duties for a period of 60 consecutive days or longer;

 

●disloyalty or dishonesty towards the Company;

 

●gross or intentional neglect of in the performance of his duties and services or material fail to perform his duties and services;

 

●his violation of any law, rule, or regulation (other than minor traffic violations) related to his duties;

 

●his material breach of any provision of the Employment Agreement or any written Inspire policy, if such breach is not cured within 10 days after written notice; and

 

●any other act or omission which harms or may reasonably be expected to harm the reputation or business interests of the Company.

 

Mr. Frank may terminate the Employment Agreement immediately for good reason, which is defined as:

 

●a material breach of the Employment Agreement by the Company, if such breach is not cured within 10 days after written notice;

 

●a material reduction in his duties or responsibilities without his consent, if such breach is not cured within 10 days after written notice;

 

●a relocation of his office to a location more than 30 miles from Virginia Beach, Virginia without his consent, if such relocation is not reversed within 10 days after written notice; and

 

●a change in control of the Company, provided that he gives notice of termination based on such change in control within six months.

 

Mr. Frank may be entitled to severance payments in certain circumstances. The Employment Agreement is governed by the laws of the Commonwealth of Virginia.

 

The foregoing description of the Employment Agreement in this Item 1.01 of this Current Report on Form 8-K is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is attached hereto as Exhibit 10.1, and which is incorporated herein by reference.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 5.02.

 

Item. 9.01. Financial Statements and Exhibits

 

Exhibit No.   Description
10.1   Employment Agreement of Richard Frank
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 16, 2024 INSPIRE VETERINARY PARTNERS, INC.
     
  By: /s/ Kimball Carr
  Name:  Kimball Carr
  Title: Chair, President and Chief Executive Officer

 

 

3

 

 EX-10.1 2 ea193965ex10-1_inspire.htm EMPLOYMENT AGREEMENT OF RICHARD FRANK

Exhibit 10.1

 

 

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (“Agreement”) is made as of January 1st, 2024, between Inspire Veterinary Partners, Inc. (“IVP” or “Company”) and Richard Frank (“Employee”).

 

Recitals:

 

A.IVP wishes to employ Employee to serve as its Chief Financial Officer Officer (“CFO”) and Employee is willing to undertake such employment in accordance with the terms of this Agreement.

 

For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is agreed as follows:

 

1.Term. The initial term of this Agreement is one (1) year. The term of this Agreement shall renew for successive one-year terms upon the affirmative vote of the Board.

 

2.Duties. Employee shall report to the Chief Executive Officer (CEO). Employee will devote as much time as is necessary to perform the duties and services required under this Agreement and as may be designated by the CEO, from time to time (collectively “Duties and Services”) and devote his best efforts to the business and affairs of IVP, the Duties and Services, and to promote the interests of IVP. Employee shall not, directly or indirectly, engage in any other business that could reasonably be expected to detract from his ability to apply his best efforts in the performance of his duties to IVP. Employee agrees to comply with all rules, regulations, and polices established or issued by and made applicable to the IVP’s employees.

 

3.Compensation.

 

3.1.Base Salary. IVP shall pay Employee an annual base salary (“Base Salary”) of $210,000.00, in equal biweekly installments. Base Salary shall be reviewed at the end of each fiscal year and any recommended changes to be approved by the Board of Directors.

 

3.2.Short-Term Incentive. Employee shall be eligible for annual bonuses (“Bonuses”) as set forth in this section. Bonuses are determined after the fiscal year end and payable by January 31 of the following year. Employee must be employed on the payout date to earn or receive any Bonuses. At a minimum, the threshold of both bonus measurements outlined below must be accomplished for payment to be made.

 

 

 

 

3.2.1.Revenue Bonus: The “Revenue Target” is 100% of budgeted revenue of IVP for the calendar year. The “Revenue Bonus Target” is 15% of Employee’s Base Salary as of December 31. The amount of the “Revenue Bonus” is determined as follows:

 

Actual Revenue Compared to Revenue Target

   Revenue Bonus
110% or greater   125% of Revenue Bonus Target
100-109%   100% of Revenue Bonus Target
95-99%   95% of Revenue Bonus Target
90-94%   90% of Revenue Bonus Target
Below 90%   No Revenue Bonus

 

3.2.2.Profit Bonus. The “Profit Target” is 100% of budgeted profit of IVP for the calendar year. The “Profit Bonus Target” is 15% of Employee’s Base Salary as of December 31. The amount of the “Profit Bonus” is determined as follows:

 

Actual Profit Compared to Profit Target

   Profit Bonus
110% or greater   125% of Profit Bonus Target
100-109%   100% of Profit Bonus Target
95-99%   95% of Profit Bonus Target
90-94%   90% of Profit Bonus Target
Below 90%   No Profit Bonus

 

3.3.Long-Term Incentive. As further compensation for the services to be performed hereunder, Employee shall be eligible to be awarded shares of the Company’s common stock as a Bonus (“Stock Bonus”), considering the Company’s performance for the calendar year based on the Revenue Bonus Target and Profit Target. The Board shall determine in its sole discretion whether a Stock Bonus is warranted and if so, the number of shares to be awarded. If the Board determines that a Stock Bonus is warranted, the value of the shares awarded, as determined by the Board in its sole discretion, shall be equal to between 10% and 14% of the Employee’s Base Salary annually as of December 31st. All shares awarded to the Employee as a Stock Bonus shall be fully vested to the Employee upon issuance.

 

3.4.Withholdings. IVP shall deduct from all compensation paid under this Agreement all taxes and other withholdings required by law.

 

3.5.Benefits. Employee shall be eligible to participate in the employee benefit plans offered to IVP’s employees on the same terms and conditions as other employees.

 

2

 

 

4.Nondisclosure.  During the course of his employment with IVP, Employee will have access to IVP’s trade secrets and proprietary and confidential information about IVP’s business (collectively, “Confidential Information”), including, but not limited to, information concerning its clients, vendors, prices, marketing strategies, research and development, strategic plan, contracts, proposals for work, planned acquisitions, and other information, all of which has independent economic value and is not available to the public. To protect IVP’s critical interest in the Confidential Information, Employee agrees that he will not, directly or indirectly, disclose or make available to anyone for use outside IVP at any time, either during or subsequent to his employment with IVP, regardless of how his employment ends, any Confidential Information, whether or not such information was developed by Employee.

 

4.1.The Defend Trade Secrets Act of 2016 provides immunity from criminal and civil liability under any Federal or State trade secret law for the disclosure of a trade secret that is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law; or is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

 

5.Non-Solicitation of Employees. Employee agrees that during his employment with IVP and for a period of two years thereafter, regardless of how his employment ends, Employee shall not, directly or indirectly, solicit or induce, or attempt to solicit or induce, any person who was an employee of IVP on Employee’s last date of employment or for six months immediately prior thereto, to leave IVP to go to work for, or consult or perform contract work for, another veterinary practice.

 

6.Non-Solicitation of Clients. Employee agrees that during his employment with IVP and for a period of two years thereafter, regardless of how his employment ends, Employee shall not, directly or indirectly, solicit or induce, or attempt to solicit or induce, any person or entity that was a client of IVP’s on Employee’s last date of employment or for one year immediately prior thereto, to seek or obtain veterinary services from any provider of veterinary services other than IVP.
   
7.Termination. This Agreement may be terminated as follows:

 

7.1.By IVP for Cause. IVP may terminate the Agreement immediately for Cause. “Cause” is defined as any of the following:

 

7.1.1.Employee’s death.
   
7.1.2.Employee’s mental or physical incapacity that prevents him, with or without reasonable accommodation, from performing his essential duties for a period of 60 consecutive days or longer.
   
7.1.3.Disloyalty or dishonesty towards IVP.
   
7.1.4.Gross or intentional neglect of in the performance of Employee’s Duties and Services or material fail to perform the Duties and Services.
   
7.1.5.Employee’s violation of any law, rule, or regulation (other than minor traffic violations) related to Employee’s duties.
   

7.1.6.Employee’s material breach of any provision of this Agreement or any written IVP policy, if such breach is not cured within 10 days after written notice.
   
7.1.7.Any other act or omission which harms or may reasonably be expected to harm the reputation or business interests of IVP

 

3

 

 

7.2.[RESERVED].

 

7.3.By Employee with Good Reason. Employee may terminate the Agreement immediately with Good Reason. “Good Reason” is defined as any of the following:

 

7.3.1.A material breach of this Agreement by IVP if such breach is not cured within 10 days after Employee’s written notice.

 

7.3.2.A material reduction in Employee’s duties or responsibilities without Employee’s consent if such breach is not cured within 10 days after Employee’s written notice.

 

7.3.3.A Change in Control, provided that Employee gives notice of termination based on a Change in Control within six months of the Change in Control’s occurrence. A “Change in Control” is defined as (a) any consolidation or merger of IVP in which IVP is not the continuing or surviving corporation or pursuant to which the stock of IVP would be converted to cash, securities, or other property, other than a merger or consolidation of IVP in which the holders of IVP’s stock immediately prior to the merger or consolidation hold more than 50% of the stock or other forms of equity of the surviving corporation immediately after the merger; (b) any sale, lease, exchange, or other transfer (in one transaction or a series of related transactions) of all, or substantially all, the assets of IVP; (c) IVP’s Board of Directors’ approval of any plan or proposal for liquidation or dissolution of IVP; or (d) any sale, lease, exchange, or other transfer (in one or a series of related transactions) to person or persons not already owning more than 50% of the issued and outstanding common stock or other forms of equity of IVP.

 

8.Severance Pay.

 

8.1.In the event this Agreement is terminated pursuant to Sections 7.3.1 or 7.3.2, IVP will provide Employee with severance pay equal to one (1) year of Employee’s then-current Base Salary, contingent on Employee executing a release of claims in a form prepared by IVP.

 

8.2.In the event this Agreement is terminated pursuant to Section 7.3.3, IVP will provide Employee with severance pay equal to (i) one (1) year of Employee’s then-current Base Salary and (ii) as determined in the sole discretion of the Board a pro rata Stock Bonus taking into account the Company’s performance for the current calendar year, all contingent on Employee executing a release of claims in a form prepared by IVP or its successor-in-interest.

 

8.3.In the event this Agreement is terminated pursuant to Sections 7.1 or 7.3, IVP will pay Employee through his last date of employment only and will have no further obligation to Employee.

 

8.4.In the event this Agreement is terminated by the Company or the Employee for any reason pursuant to any of the Sections herein, the Company shall use good faith commercially reasonable efforts to have Employee released from any and all guarantees given by the Employee for the benefit of the Company, including, but not limited to providing an acceptable substitute guarantor for the obligation.

 

9.Section 409A. It is the intention of IVP that all payments and benefits under this Agreement shall be made and provided in a manner that is either exempt from or intended to avoid taxation under Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), to the extent applicable. Any ambiguity in this Agreement shall be interpreted to comply with Section 409A. Employee acknowledges that IVP has made no representations as to the treatment of the compensation and benefits provided in this Agreement and that he has been advised to obtain his own tax advice. Each amount or benefit payable pursuant to this Agreement shall be deemed a separate payment for purposes of Section 409A.

 

4

 

 

10.Miscellaneous.

 

10.1.Modifications. This Agreement may be altered or amended in whole or in part only by a written instrument signed by the IVP and Employee setting forth such changes.

 

10.2.Restrictive Covenants of the Essence. This Agreement’s restrictive covenants, set forth in Sections 4 through 6 (“Restrictive Covenants”), are of the essence of this Agreement and will be construed as independent of any other provision in this Agreement. The existence of any claim or cause of action of the Employee against IVP, whether predicated on this Agreement or not, will not constitute a defense to IVP’s enforcement of this Agreement’s restrictive covenants.

 

10.3.Injunctive Relief. IVP and Employee agree that irreparable injury will result to IVP in the event Employee violates any Restrictive Covenant and Employee acknowledges that the remedies at law for any breach by Employee of a Restrictive Covenant will be inadequate and that IVP will be entitled to injunctive relief, without the necessity of posting a bond, against Employee, in addition to any other remedy that is available, at law or in equity. Employee agrees that the Restrictive Covenants will be extended by the length of time which Employee will have been in breach of any of the provisions.

 

10.4.Survivability. The Restrictive Covenants survive the termination of this Agreement.

 

10.5.Successors and Assigns. This Agreement shall be binding upon, and inure to the benefit of, the parties hereto and their legal successors and assigns.

 

10.6.Severability. Should any one or more of the provisions hereof be deemed to be illegal or unenforceable, all other provisions hereof shall be given effect separately therefrom and shall not be affected thereby.

 

10.7.Attorney’s Fees. In any action at law or in equity to enforce any of the provisions or rights under this Agreement, the unsuccessful party to such litigation as determined by the court in a final judgment or decree, shall pay the successful party all costs, expenses and reasonable attorney’s fees incurred therein by such party or parties (including, without limitation, such costs, expenses and fees on any appeals), and if such successful parties shall recover judgment in any action or proceeding, such costs, expenses and attorney’s fees shall be included as part of such judgment.

 

10.8.Governing Law and Venue. This Agreement shall be construed, interpreted and applied according to the laws of the Commonwealth of Virginia. Any dispute arising under or related to this Agreement shall be heard in the Circuit Court for Virginia Beach, Virginia, which will have exclusive jurisdiction over all such disputes. The parties waive any objection to personal jurisdiction in that court.

 

10.9.Jury Waiver. The parties waive any right to a jury trial in any dispute arising under or related to this Agreement and agree that all such disputes shall be tried to a judge without a Jury.

 

10.10.Entire Agreement. This Agreement and the Existing Agreement(s) constitute the entire understanding between the parties hereto concerning the subject matter thereof and supersede all other agreements, whether oral or written, between the parties on those subject matters.

 

5

 

 

WITNESS THE FOLLOWING SIGNATURES:

 

INSPIRE VETERINARY PARTNERS, INC.

 

/s/ Lynley Kees  
Vice President, Human Resources Date: 1/29/2024
   
By:            
   
/s/ Richard Frank 1/26/2024
Richard Frank  

 

 

6

 

 EX-101.SCH 3 ivp-20240101.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ivp-20240101_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ivp-20240101_pre.xml XBRL PRESENTATION FILE GRAPHIC 6 ex10-1_001.jpg GRAPHIC begin 644 ex10-1_001.jpg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htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Jan. 01, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 01, 2024
Entity File Number 001-41792
Entity Registrant Name INSPIRE VETERINARY PARTNERS, INC.
Entity Central Index Key 0001939365
Entity Tax Identification Number 85-4359258
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 780 Lynnhaven Parkway, Suite 400
Entity Address, City or Town Virginia Beach
Entity Address, State or Province VA
Entity Address, Postal Zip Code 23452
City Area Code 757
Local Phone Number 734-5464
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, par value $0.0001
Trading Symbol IVP
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://inspirevet.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea193965-8k_inspire.htm ivp-20240101.xsd ivp-20240101_lab.xml ivp-20240101_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea193965-8k_inspire.htm": { "nsprefix": "IVP", "nsuri": "http://inspirevet.com/20240101", "dts": { "inline": { "local": [ "ea193965-8k_inspire.htm" ] }, "schema": { "local": [ "ivp-20240101.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ivp-20240101_lab.xml" ] }, "presentationLink": { "local": [ "ivp-20240101_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://inspirevet.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea193965-8k_inspire.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea193965-8k_inspire.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001213900-24-014906-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-014906-xbrl.zip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end XML 17 ea193965-8k_inspire_htm.xml IDEA: XBRL DOCUMENT 0001939365 2024-01-01 2024-01-01 iso4217:USD shares iso4217:USD shares false 0001939365 8-K 2024-01-01 INSPIRE VETERINARY PARTNERS, INC. NV 001-41792 85-4359258 780 Lynnhaven Parkway, Suite 400 Virginia Beach VA 23452 757 734-5464 false false false false Class A Common Stock, par value $0.0001 IVP NASDAQ true false